Or. Admin. R. 333-007-0341 - Compliance Testing Requirements for Finished Inhalable Cannabinoid Products

(1) A processor or processing site must test every process lot of a finished inhalable Cannabinoid product prior to selling or transferring the product for the following:

(a) Pesticides in accordance with OAR 333-007-0400.

(b) Solvents in accordance with OAR 333-007-0410.

(c) Adult use cannabinoid and CBD concentration in accordance with OAR 333-007-0430.

(d) Heavy metals in accordance with OAR 333-007-0415 if the finished inhalable cannabinoid product is or was manufactured on or after March 1, 2023.

(e) Mycotoxins in accordance with OAR 333-007-0425 finished inhalable cannabinoid product is or was manufactured on or after July 1, 2022.

(f) Microbiological contaminants in accordance with OAR 333-007-0390 finished inhalable cannabinoid product is or was manufactured on or after March 1, 2023.

(2) In lieu of ordering and arranging for the sampling and testing required in this rule a processor may transport batches of finished inhalable Cannabinoid products to a wholesaler licensed by the Commission under ORS 475C.093 and the wholesaler may order and arrange for the sampling and testing of the batches, in accordance with rules established by the Commission.

(3) To the extent that the testing required under this rule is also required under OAR 333-007-0340, a processor or processing site is only required to comply with the testing under this rule.

Notes

Or. Admin. R. 333-007-0341

PH 24-2022, adopt filed 03/15/2022, effective 3/31/2022

Statutory/Other Authority: ORS 475C.544

Statutes/Other Implemented: ORS 475C.544